Vivani Medical: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Vivani Medical (NASDAQ:VANI) reported Q3 earnings with an EPS of $-0.13, missing estimates by 8.33% and showing no revenue growth from the same period last year. The company's previous earnings miss was followed by a 10.66% share price drop the next day.
November 14, 2023 | 2:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vivani Medical reported a Q3 EPS of $-0.13, missing estimates by 8.33%, with no revenue growth compared to last year. Previous earnings miss led to a 10.66% stock price decline.
Given the earnings miss and the historical reaction to the previous quarter's miss, it is likely that VANI's stock price will experience a short-term decline. The lack of revenue growth could further concern investors, potentially exacerbating the negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100